Mom is HIV - and father of baby is HIV+. The mom is on Truvada daily. Can she breastfeed?
Announcement
Collapse
No announcement yet.
Welcome to our forum! Before posting your questions, please read the following terms:
- 1. Forum questions will be responded to by InfantRisk staff as schedules permit during normal business hours.
- 2. This forum is not intended for emergencies or urgent care. For any immediate medical concerns, please seek appropriate medical attention.
- 3. Any statements made by team members should be discussed with your medical care team. Your healthcare providers know you (and your baby) best, and should have a better understanding of your unique situation.
- 4. We are a small team dedicated to helping you as best as we can. However, for the quickest response, we recommend calling the InfantRisk Center at +1(806) 352-2519.
By posting to the forums, you acknowledge and agree to these terms.
The InfantRisk team
Breastfeeding and Truvada
Collapse
X
-
Janine:
We don't really know if it is safe. Below is the current data. It would really depend on how well it works in suppressing the virus.
If it drops the virus to almost Zero, then it would probably be relatively safe to use. But long-term exposure to the infant is worrisome. Honestly, we simply don't know if it is safe.
Tom Hale Ph.D.
Emtricitabine and Tenofovir disoproxil fumarate is a combination drug product indicated for use in HIV infections. From a study conducted to investigate the concentrations of emtricitabine and tenofovir in the breastmilk samples of 5 HIV-infected women, it was found that breastmilk concentrations of emtricitabine and tenofovir were 2% and 0.03% respectively, of the normal oral dose administered to an infant.[1] These women were treated with emtricitabine 400 mg/tenofovir 600 mg, at the time of delivery, followed by emtricitabine 200 mg/tenofovir 300 mg daily for 7 days postpartum. The breastmilk concentrations for emtricitabine were 177-679 ng/mL, while those for tenofovir were 6.8-14.1 ng/mL. Considering this, the relative infant dose for emtricitabine ranges from 0.9-3.6% while those for tenofovir ranges from 0.02-0.5%.
Comment